Baylor College of Medicine, Michael E. DeBakey Department of Surgery, Houston, TX.
Department of Surgery, Ohio State University, Columbus, Ohio.
J Surg Res. 2019 Apr;236:332-339. doi: 10.1016/j.jss.2018.11.048. Epub 2019 Jan 4.
Early drain removal when postoperative day (POD) one drain fluid amylase (DFA) was ≤5000 U/L reduced complications in a previous randomized controlled trial. We hypothesized that most surgeons continue to remove drains late and this is associated with inferior outcomes.
We assessed the practice of surgeons in a prospectively maintained pancreas surgery registry to determine the association between timing of drain removal with demographics, comorbidities, and complications. We selected patients with POD1 DFA ≤5000 U/L and excluded those without drains, and subjects without data on POD1 DFA or timing of drain removal. Early drain removal was defined as ≤ POD5.
Two hundred and forty four patients met inclusion criteria. Only 90 (37%) had drains removed early. Estimated blood loss was greater in the late removal group (190 mL versus 100 mL, P = 0.005) and pathological findings associated with soft gland texture were more frequent (97 [63%] versus 35 [39%], P < 0.0001). Patients in the late drain removal group had more complications (84 [55%] versus 30 [33%], P = 0.001) including pancreatic fistula (55 [36%] versus 4 [4%], P < 0.0001), delayed gastric emptying (27 [18%] versus 3 [3%], P = 0.002), and longer length of stay (7 d versus 5 d, P < 0.0001). In subset analysis for procedure type, complications and pancreatic fistula remained significant for both pancreatoduodenectomy and distal pancreatectomy.
Despite level one data suggesting improved outcomes with early removal when POD1 DFA is ≤ 5000 U/L, experienced pancreas surgeons more frequently removed drains late. This practice was associated with known risk factors (estimated blood loss, soft pancreas) and may be associated with inferior outcomes suggesting potential for improvement.
在之前的一项随机对照试验中,当术后第 1 天(POD)的引流液淀粉酶(DFA)≤5000 U/L 时,早期拔管可减少并发症。我们假设大多数外科医生仍然会延迟拔管,这与较差的结果有关。
我们评估了一个前瞻性维持的胰腺外科登记处的外科医生的实践,以确定引流管拔管时间与人口统计学、合并症和并发症之间的关联。我们选择了 POD1 DFA≤5000 U/L 的患者,并排除了没有引流管的患者,以及没有 POD1 DFA 或引流管拔管时间数据的患者。早期拔管定义为≤POD5。
244 名患者符合纳入标准。只有 90 名(37%)患者进行了早期拔管。晚期拔管组的估计失血量更大(190 毫升比 100 毫升,P=0.005),且与软胰腺质地相关的病理发现更为常见(97 [63%]比 35 [39%],P<0.0001)。晚期引流管拔除组的并发症更多(84 [55%]比 30 [33%],P=0.001),包括胰瘘(55 [36%]比 4 [4%],P<0.0001)、胃排空延迟(27 [18%]比 3 [3%],P=0.002)和住院时间延长(7 天比 5 天,P<0.0001)。在手术类型的亚组分析中,胰十二指肠切除术和胰体尾切除术的并发症和胰瘘仍然有统计学意义。
尽管一级数据表明,当 POD1 DFA≤5000 U/L 时,早期拔管可改善预后,但经验丰富的胰腺外科医生更常延迟拔管。这种做法与已知的危险因素(估计失血量、软胰腺)有关,可能与较差的结果有关,这表明有改进的潜力。